Machine Learning Approach for Metabolic Syndrome Diagnosis Using Explainable Data-Augmentation-Based Classification.
Mohammed G SghaireenYazan Al-SmadiAhmad Al-QeremKumar Chandan SrivastavaKiran Kumar GanjiMohammad Khursheed AlamShadi NashwanYousef KhaderPublished in: Diagnostics (Basel, Switzerland) (2022)
Metabolic syndrome (MetS) is a cluster of risk factors including hypertension, hyperglycemia, dyslipidemia, and abdominal obesity. Metabolism-related risk factors include diabetes and heart disease. MetS is also linked to numerous cancers and chronic kidney disease. All of these variables raise medical costs. Developing a prediction model that can quickly identify persons at high risk of MetS and offer them a treatment plan is crucial. Early prediction of metabolic syndrome will highly impact the quality of life of patients as it gives them a chance for making a change to the bad habit and preventing a serious illness in the future. In this paper, we aimed to assess the performance of various algorithms of machine learning in order to decrease the cost of predictive diagnoses of metabolic syndrome. We employed ten machine learning algorithms along with different metaheuristics for feature selection. Moreover, we examined the effects of data augmentation in the prediction accuracy. The statistics show that the augmentation of data after applying feature selection on the data highly improves the performance of the classifiers.
Keyphrases
- machine learning
- metabolic syndrome
- big data
- artificial intelligence
- risk factors
- end stage renal disease
- chronic kidney disease
- insulin resistance
- deep learning
- electronic health record
- uric acid
- type diabetes
- blood pressure
- cardiovascular risk factors
- peritoneal dialysis
- cardiovascular disease
- ejection fraction
- data analysis
- soft tissue
- newly diagnosed
- weight loss
- oxidative stress
- patient reported outcomes
- adipose tissue
- high fat diet induced
- current status